Quantum Genomics Quantum Genomics
  • Company
    • Management
    • Board of directors
    • Inventors
    • Scientific and clinical advisory board
  • Investors
    • Press releases
    • Financial documents
      • Annual information
      • Semi-annual information
      • Other regulated informations
    • Shareholder letter
    • General meetings
    • Shareholding
    • Financial calendar
    • Contacts
  • Contact us
News

Quantum Genomics Secures €3 Million Non-dilutive Financing

Quantum on 28 April 2021

Quantum Genomics Secures €3 Million Non-dilutive Financing

Read the press realease

Previous Post (p) Quantum Genomics will Present Top-line Results from its QUORUM study at European Society of Cardiology (ESC) Meeting
Next Post (n) QUORUM study: Results Announcement next August 27, 2021 at 10:30 am CEST
Quantum 2021-04-28T18:23:34+02:00
About

Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high blood pressure and heart failure.

Contact us

33 rue Marbeuf
75008 Paris

[email protected]
+33(0)1 85 34 77 70

Write us

Quick access
  • Scientific Publications
Search

 

© 2019 Quantum Genomics - Legal notice - Website terms and conditions

  • Company
    • Management
    • Board of directors
    • Inventors
    • Scientific and clinical advisory board
  • Investors
    • Press releases
    • Financial documents
      • Annual information
      • Semi-annual information
      • Other regulated informations
    • Shareholder letter
    • General meetings
    • Shareholding
    • Financial calendar
    • Contacts
  • Contact us
  • Blog
  • Home
  • Contact us